Skip to main content
Moleculin, Norwegian university partner on immune stimulation drug study
10/12/2017

Moleculin Biotech agreed to work together with Norway-based University of Bergen to advance research of Moleculin's WP1066 for patients with glioblastoma and melanoma. A clinical trial of the drug candidate is expected to start by the end of this year.

Full Story: